Evidence map›Paper›PMID 39186217›Full record

ArticleInfection2025

Disseminated fusariosis after allogenic hematopoietic stem cell transplantation: case report.

A Gantner, J B Hagemann, B Grüner, G Walther, A Neagoie, V Wais, H Döhner, E Sala

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

A GantnerDepartment of Internal Medicine III, University Hospital Ulm, Albert-Einstein-Allee 23, D-89081, Ulm, Germany. andrea.gantner@uniklinik-ulm.de.
J B HagemannInstitute of Medical Microbiology and Hygiene, University Hospital of Ulm, Albert-Einstein-Allee 23, D-89081, Ulm, Germany.
B GrünerDepartment of Internal Medicine III, University Hospital Ulm, Albert-Einstein-Allee 23, D-89081, Ulm, Germany.
G WaltherNational Reference Center for Invasive Fungal Infections (NRZMyk), Leibniz Institute of Natural Product Research and Infection Biology-Hans Knöll Institute, Jena, Germany.
A NeagoieDepartment of Internal Medicine III, University Hospital Ulm, Albert-Einstein-Allee 23, D-89081, Ulm, Germany.
V WaisDepartment of Internal Medicine III, University Hospital Ulm, Albert-Einstein-Allee 23, D-89081, Ulm, Germany.
H DöhnerDepartment of Internal Medicine III, University Hospital Ulm, Albert-Einstein-Allee 23, D-89081, Ulm, Germany.
E SalaDepartment of Internal Medicine III, University Hospital Ulm, Albert-Einstein-Allee 23, D-89081, Ulm, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In allogenic stem cell recipients, invasive fungal disease is a common yet dreaded complication with high mortality. Among these, fusariosis is especially complex to treat due to high intrinsic resistance and few antimycotic options, requiring close cooperation of all involved departments. We here report an instructive case of disseminated fusariosis after allogenic stem cell transplantation with fatal outcome despite maximum treatment.

Indexed as

FusariosisHematopoietic Stem Cell TransplantationAntifungal AgentsFatal OutcomeHumansTransplantation, HomologousAntifungal AgentsAllogenic hematopoietic stem cell transplantationFungal infectionFusariosisFusarium

Identifiers

PMID39186217
PMCPMC11971186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.